STOCK TITAN

Inspire Medical Systems, Inc. to Report First Quarter 2021 Financial Results on May 4, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will release its first quarter 2021 financial results on May 4, 2021, after market close. A conference call will follow at 5:00 p.m. Eastern Time for management to discuss results and recent developments. Inspire focuses on innovative solutions for obstructive sleep apnea and offers the only FDA-approved neurostimulation therapy for this condition. For further information, visit www.inspiresleep.com.

Positive
  • Inspire offers the first FDA-approved neurostimulation technology for obstructive sleep apnea.
Negative
  • None.

MINNEAPOLIS, April 06, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the first quarter 2021 after the close of trading on Tuesday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, May 4th @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13717525
Webcast: http://public.viavid.com/index.php?id=143909

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989


FAQ

When will Inspire Medical Systems report its Q1 2021 financial results?

Inspire Medical Systems will report its Q1 2021 financial results on May 4, 2021.

What time is the Inspire conference call for Q1 2021 results?

The conference call for Q1 2021 results will be held at 5:00 p.m. Eastern Time on May 4, 2021.

What is Inspire Medical Systems known for?

Inspire Medical Systems is known for developing innovative solutions for obstructive sleep apnea, including the first FDA-approved neurostimulation therapy.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

5.58B
29.36M
1.95%
113.89%
6.52%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY